Loading...
Zebrafish: An Attractive Model to Study Staphylococcus aureus Infection and Its Use as a Drug Discovery Tool.
Rasheed, Sari Fries, Franziska
Rasheed, Sari
Fries, Franziska
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2021-06-21
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 667.56 KB
Other Titles
Abstract
Non-mammalian in vivo disease models are particularly popular in early drug discovery. Zebrafish (Danio rerio) is an attractive vertebrate model, the success of which is driven by several advantages, such as the optical transparency of larvae, the small and completely sequenced genome, the small size of embryos and larvae enabling high-throughput screening, and low costs. In this review, we highlight zebrafish models of Staphyloccoccus aureus infection, which are used in drug discovery and for studying disease pathogenesis and virulence. Further, these infection models are discussed in the context of other relevant zebrafish models for pharmacological and toxicological studies as part of early drug profiling. In addition, we examine key differences to commonly applied models of S.aureus infection based on invertebrate organisms, and we compare their frequency of use in academic research covering the period of January 2011 to January 2021.
Citation
Pharmaceuticals (Basel). 2021 Jun 21;14(6):594. doi: 10.3390/ph14060594.
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1424-8247
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International